MTOR and kidney disorder: With regard to immune diseases, the miR-766-3p levels in the serum of systemic lupus erythematosus patients with renal disorder have been found to be decreased in comparison to patients without renal disorder, suggesting that this miRNA may play a pivotal role in the PI3K-AKT-mTOR pathway [28].